CeMMEC13;CeMMEC13 >=98% (HPLC);CeMMEC13, 10 mM in DMSO;Inhibitor,CeMMEC13,DNA/RNA Synthesis,CeMMEC-13,CeMMEC 13,inhibit;N-(2,3-Dihydro-1,4-benzodioxin-6-yl)-1-methyl-2-oxo-1,2-dihydro-4-quinolinecarboxamide;4-Quinolinecarboxamide, N-(2,3-dihydro-1,4-benzodioxin-6-yl)-1,2-dihydro-1-methyl-2-oxo-;N-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-methyl-2-oxo-1,2-dihydroquinoline-4-carboxamide;N-?(2,?3-Dihydro-?1,?4-?benzodioxin-?6-?yl)?-?1,?2-?dihydro-?1-?methyl-?2-?oxo-4-?quinolinecarboxamide?
N-?(2,?3-Dihydro-?1,?4-?benzodioxin-?6-?yl)?-?1,?2-?dihydro-?1-?methyl-?2-?oxo-4-?quinolinecarboxamide? is an isoquinolinone compound and an inhibitor of TAF1, a TATA-binding protein Associated Factor (TAF) of the RNA polymerase II transcription initiation factor complex TFIID (1,2).